Vabysmo, Ondexxya, Ozempic 2 mg Pen Now Available in Japan

May 26, 2022
A throng of new medicines and products with additional dosage forms joined the NHI price list on May 25, with some of them launched the same day including Vabysmo (faricimab), the first bispecific antibody for eyes developed by Chugai Pharmaceutical...read more